Cargando…

[(18)F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound

Focused ultrasound in combination with microbubbles (FUS) provides an effective means to locally enhance the delivery of therapeutics to the brain. Translational and quantitative imaging techniques are needed to noninvasively monitor and optimize the impact of FUS on blood-brain barrier (BBB) permea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hugon, Gaëlle, Goutal, Sébastien, Dauba, Ambre, Breuil, Louise, Larrat, Benoit, Winkeler, Alexandra, Novell, Anthony, Tournier, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621256/ https://www.ncbi.nlm.nih.gov/pubmed/34834167 http://dx.doi.org/10.3390/pharmaceutics13111752

Ejemplares similares

Impact of Donepezil on Brain Glucose Metabolism Assessed Using [(18)F]2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of Alzheimer’s Disease Induced by Intracerebroventricular Injection of Amyloid-Beta Peptide
por: Hugon, Gaëlle, et al.
Publicado: (2022)

Efficient PD-L1 imaging of murine glioblastoma with FUS-aided immunoPET by leveraging FcRn-antibody interaction
por: Chevaleyre, Céline, et al.
Publicado: (2023)

Recent Advances on Ultrasound Contrast Agents for Blood-Brain Barrier Opening with Focused Ultrasound
por: Dauba, Ambre, et al.
Publicado: (2020)

Validation of a pharmacological imaging challenge using (11)C-buprenorphine and (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography to study the effects of buprenorphine to the rat brain
por: Soyer, Amélie, et al.
Publicado: (2023)

Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [(11)C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier
por: Breuil, Louise, et al.
Publicado: (2022)

Regulation of P-glycoprotein and Breast Cancer Resistance Protein Expression Induced by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption: A Pilot Study
por: Conti, Allegra, et al.
Publicado: (2022)

Ultrasound-Mediated Blood-Brain Barrier Opening Improves Whole Brain Gene Delivery in Mice
por: Felix, Marie-Solenne, et al.
Publicado: (2021)

[(18)F]2-Fluoro-2-deoxy-d-glucose PET/CT in mediastinal masses
por: Rankin, S.
Publicado: (2010)

Comparison of the Blood–Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug–Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging
por: Breuil, Louise, et al.
Publicado: (2022)

Optimal 2-[(18)F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma
por: Horsager, Jacob, et al.
Publicado: (2016)

2-Deoxy-2-fluoro-d-glucose metabolism in Arabidopsis thaliana
por: Fatangare, Amol, et al.
Publicado: (2015)

2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
por: Plöckinger, U., et al.
Publicado: (2018)

Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[(18)F]-Fluoro-L-Thymidine ([(18)F]FLT) Positron Emission Tomography (PET)
por: Ullrich, Roland T., et al.
Publicado: (2008)

Kikuchi-Fujimoto disease mimicking malignant lymphoma with 2-[(18)F]fluoro-2-deoxy-D-glucose PET/CT in children
por: Kim, Ji Eun, et al.
Publicado: (2014)

Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging
por: Sardana, Malvika, et al.
Publicado: (2022)

6-Deoxy-6-fluoro-d-galactose
por: Jenkinson, Sarah F., et al.
Publicado: (2010)

1-Deoxy-1-fluoro-l-galactitol
por: Jenkinson, Sarah F., et al.
Publicado: (2010)

Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)
por: Mirzaei, Siroos, et al.
Publicado: (2003)

Metabolic liver function in humans measured by 2-(18)F-fluoro-2-deoxy-D-galactose PET/CT–reproducibility and clinical potential
por: Bak-Fredslund, Kirstine P., et al.
Publicado: (2017)

Clinical Utility of (18)F-2-Fluoro-deoxy-d-glucose PET Imaging in Locally Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma
por: Cowzer, Darren, et al.
Publicado: (2023)

Radiotherapeutic use of 2-deoxy-2-[(18)F]fluoro-D-glucose – a comment
por: Meyer, Michael Andrew
Publicado: (2004)

Evaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
por: Jirka, Silvana M G, et al.
Publicado: (2015)

Safety evaluation of 2′-deoxy-2′-fluoro nucleotides in GalNAc-siRNA conjugates
por: Janas, Maja M, et al.
Publicado: (2019)

Opportunities for 2-[(18)F] Fluoro-2-Deoxy-D-Glucose PET/CT in Cervical-Vaginal Neuroendocrine Carcinoma: Case Series and Literature Review
por: Lin, Yin, et al.
Publicado: (2012)

Is 2-deoxy-2-[(18)F]fluoro-D-glucose PET/CT acquisition from the upper thigh to the vertex of skull useful in oncological patients?
por: Salvatore, B., et al.
Publicado: (2014)

Dynamic 2-deoxy-2[18F] fluoro-D-glucose PET/MRI in human renal allotransplant patients undergoing acute kidney injury
por: Pajenda, Sahra, et al.
Publicado: (2020)

Evidencing leprosy neuronal inflammation by 18-Fluoro-deoxy-glucose
por: Penna, Patricia Sola, et al.
Publicado: (2023)

18F‐fluoro‐2‐deoxy‐2‐d‐glucose PET‐CT (FDG PET‐CT) in staging of high‐risk renal and urothelial bladder cancers (COPPER‐T) trial protocol
por: Jena, Rahul, et al.
Publicado: (2023)

Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats
por: Amor, Dorra, et al.
Publicado: (2018)

Applications of 2-deoxy-2-fluoro-D-glucose (FDG) in Plant Imaging: Past, Present, and Future
por: Fatangare, Amol, et al.
Publicado: (2016)

Synthesis of 4′-Substituted-2′-Deoxy-2′-α-Fluoro Nucleoside Analogs as Potential Antiviral Agents
por: Kasthuri, Mahesh, et al.
Publicado: (2020)

G-quadruplex induced stabilization by 2′-deoxy-2′-fluoro-d-arabinonucleic acids (2′F-ANA)
por: Peng, Chang Geng, et al.
Publicado: (2007)

(18)F-fluoro-2-deoxy-D-glucose positron emission tomography findings of neurolymphomatosis
por: Jung, Yun Hwa, et al.
Publicado: (2014)

Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002)
por: Bourguet, P, et al.
Publicado: (2003)

PET Imaging of Fructose Metabolism in a Rodent Model of Neuroinflammation with 6-[(18)F]fluoro-6-deoxy-D-fructose
por: Boyle, Amanda J., et al.
Publicado: (2022)

Improvements in siRNA properties mediated by 2′-deoxy-2′-fluoro-β-d-arabinonucleic acid (FANA)
por: Dowler, Thomas, et al.
Publicado: (2006)

Positron emitting (18)F-2-deoxy-2-fluoro-D-glucose: potential hot new therapy
por: Mortimer, Joanne E, et al.
Publicado: (2003)

Detection of Gastroesophageal Reflux Esophagitis Using 2-fluoro-2-deoxy-d-glucose Positron Emission Tomography
por: Tsai, Min-Kuei, et al.
Publicado: (2012)

Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
por: Wang, Fu-Li, et al.
Publicado: (2016)

TMSOTf assisted synthesis of 2’-deoxy-2’-[(18)F]fluoro-β-D-arabinofuranosylcytosine ([(18)F]FAC)
por: Gangangari, Kishore K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p5jh39ackid3liio5k5hc0sqt3